Satellos Bioscience (TSX:MSCL) Short-Term Capital Lease Obligation : C$0.00 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience Short-Term Capital Lease Obligation?

Satellos Bioscience's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$0.00 Mil.

Satellos Bioscience Short-Term Capital Lease Obligation Historical Data

The historical data trend for Satellos Bioscience's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Satellos Bioscience Short-Term Capital Lease Obligation Chart

Satellos Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Satellos Bioscience Quarterly Data
	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										-	-	-	-	-

Satellos Bioscience Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Satellos Bioscience Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Satellos Bioscience (TSX:MSCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

MSCLF:USA 0IT:Germany

Address

65 Front Street East, Suite 201, Toronto, ON, CAN, M5E 1B5

Website

https://www.satellos.com

Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience (TSX:MSCL) Headlines

No Headlines